Society Letters

Endocrine Society Comments on NIH COVID Strategic Plan

December 02, 2020

To: Francis Collins, MD, PhD, Director, National Institutes of Health

"The Endocrine Society appreciates the opportunity to respond to the Request for Information inviting feedback on the NIH-Wide Strategic Plan for COVID-19 Research. Founded in 1916, the Endocrine Society is the world’s oldest, largest, and most active organization dedicated to research on hormones and the clinical treatment of patients with endocrine diseases. Our members include leading experts on endocrine-related comorbidities for COVID-19, as well as the use of hormone-based therapies such as glucocorticoids, testosterone, and triiodothyronine. We welcome the Strategic Plan for COVID-19 Research and support NIH’s approach to continually updated the Plan to reflect new challenges presented by COVID-19. In our comments, we identify research priorities that NIH should include in future iterations of the Strategic Plan."

arrowRead the Full Letter

Last Updated:
Take Action

Make Your Voice Heard

Take Action
Join us in lending your voice to our online advocacy to support our policy priorities, endocrinology, and science. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.

Join us in lending your voice to our online advocacy to support our policy priorities, endocrinology, and science. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.

Back to top
Short on time?

We'll come to you...

Get updates on the latest breakthroughs, clinical practice guidelines, and career development opportunities, straight to your inbox

Then take the next step: Set up your free website account and get exclusive access to even more great tools & content!